To Study the Effect of Disodium Cromoglycate on Serum Immunoglobulin Levels in Bronchial Asthma Patients
International Journal of Drug Delivery Technology · 16.11.2026 · 16 (80s)
DOI: 10.25258/ijddt.16.80s.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.11.2026. Verfasst von Aashi Aashi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Two hundred asthmatic patients were selected for the study of their immunoglobulin level, out of these one hundred eighty three patients were receiving disodium cromoglycate (DSCG) as an anti-allergic drug. We found DSCG inhibit IgE production in the patients of bronchial asthma while the production of IgM, IgG and IgA was not affected. Our study proves that disodium Cromo glycate is very useful in lowering down the concentration of IgE level in asthmatic patients.
Zitieren
APA
Aashi, A., Kumar, S., Rana, S. S., Sagar, S., & Singh, G. (2026). To Study the Effect of Disodium Cromoglycate on Serum Immunoglobulin Levels in Bronchial Asthma Patients. International Journal of Drug Delivery Technology, 16(80s). https://doi.org/10.25258/ijddt.16.80s.6
Vancouver
Aashi A, Kumar S, Rana SS, Sagar S, Singh G. To Study the Effect of Disodium Cromoglycate on Serum Immunoglobulin Levels in Bronchial Asthma Patients. International Journal of Drug Delivery Technology. 2026;16(80s). doi:10.25258/ijddt.16.80s.6
BibTeX
@article{Aashi2026,
author = {Aashi, Aashi and Kumar, Saurav and Rana, Satyapal Singh and Sagar, Sagar and Singh, Gajendra},
title = {To Study the Effect of Disodium Cromoglycate on Serum Immunoglobulin Levels in Bronchial Asthma Patients},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {80s},
doi = {10.25258/ijddt.16.80s.6}
}
EUVIMED